Treatment trajectories and outcome for patients with CLL. (A) The possible treatment paths for a patient with CLL meeting the criteria for treatment. (B) An example Kaplan-Meier curve for progression-free survival from the study forming the basis for cost-effectiveness analyses by Patel et al; the fraction of patients truly benefitting from targeted therapy is shaded in yellow.